Tekla Healthcare Investors Stock Annual Yield
| HQH Stock | USD 16.82 0.52 3.00% |
Tekla Healthcare Investors fundamentals help investors to digest information that contributes to Tekla Healthcare's financial success or failures. It also enables traders to predict the movement of Tekla Stock. The fundamental analysis module provides a way to measure Tekla Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tekla Healthcare stock.
Tekla |
Tekla Healthcare Investors Company Annual Yield Analysis
Tekla Healthcare's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Tekla Healthcare Annual Yield | 0.09 % |
Most of Tekla Healthcare's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tekla Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Tekla Healthcare Investors has an Annual Yield of 0.0949%. This is much higher than that of the Capital Markets sector and significantly higher than that of the Financials industry. The annual yield for all United States stocks is notably lower than that of the firm.
Tekla Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Healthcare's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics of similar companies.Tekla Healthcare is currently under evaluation in annual yield category among related companies.
Tekla Fundamentals
| Return On Equity | 0.061 | |||
| Return On Asset | -8.0E-4 | |||
| Profit Margin | 5.47 % | |||
| Operating Margin | (0.22) % | |||
| Current Valuation | 864.74 M | |||
| Shares Outstanding | 50.62 M | |||
| Shares Owned By Institutions | 26.67 % | |||
| Number Of Shares Shorted | 36.82 K | |||
| Price To Earning | 3.38 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 76.62 X | |||
| Revenue | 58.12 M | |||
| Gross Profit | 8.27 M | |||
| EBITDA | 56.33 M | |||
| Net Income | 56.33 M | |||
| Cash And Equivalents | 62 | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 3.21 X | |||
| Book Value Per Share | 18.84 X | |||
| Cash Flow From Operations | (65.41 M) | |||
| Short Ratio | 0.18 X | |||
| Earnings Per Share | 1.09 X | |||
| Number Of Employees | 13 | |||
| Beta | 0.74 | |||
| Market Capitalization | 885.43 M | |||
| Total Asset | 932.49 M | |||
| Retained Earnings | 5.97 M | |||
| Annual Yield | 0.09 % | |||
| Five Year Return | 8.90 % | |||
| Net Asset | 932.49 M | |||
| Last Dividend Paid | 1.61 |
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:Check out Tekla Healthcare Piotroski F Score and Tekla Healthcare Altman Z Score analysis. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Tekla Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.